ARTICLE

FindCenter AddIcon

Largest Ever Psychedelics Study Maps Changes of Conscious Awareness to Neurotransmitter Systems

By Neuroscience News — 2022

In the world’s largest study on psychedelics and the brain, a team of researchers from The Neuro (Montreal Neurological Institute-Hospital) and Department of Biomedical Engineering of McGill University, the Broad Institute at Harvard/MIT, SUNY Downstate Health Sciences University, and Mila—Quebec Artificial Intelligence Institute have shown how drug-induced changes in subjective awareness are anatomically rooted in specific neurotransmitter receptor systems.

Read on neurosciencenews.com

FindCenter Post-Image

Chronic, Intermittent Microdoses of the Psychedelic N,N-Dimethyltryptamine (DMT) Produce Positive Effects on Mood and Anxiety in Rodents

Taken together, our results suggest that psychedelic microdosing may alleviate symptoms of mood and anxiety disorders, though the potential hazards of this practice warrant further investigation.

Article
Lindsay P. Cameron, Charlie J. Benson, Brian C. DeFelice, Oliver Fiehn, and David E. Olson
2019
FindCenter AddIcon
FindCenter Post-Image

DMT Alters Cortical Travelling Waves

These results support a recent model proposing that psychedelics reduce the ‘precision-weighting of priors’, thus altering the balance of top-down versus bottom-up information passing.

Article
Andrea Alamia, Christopher Timmermann, David J Nutt, Rufin VanRullen, Robin L Carhart-Harris
2020
FindCenter AddIcon
FindCenter Post-Image

The Trip Treatment

Research into psychedelics, shut down for decades, is now yielding exciting results.

Article
Michael Pollan
2015
FindCenter AddIcon
FindCenter Post-Image

How Ecstasy and Psilocybin Are Shaking Up Psychiatry

Regulators will soon grapple with how to safely administer powerful psychedelics for treating depression and post-traumatic stress disorder.

Article
Paul Tullis
2021
FindCenter AddIcon
FindCenter Post-Image

The Return of Psychedelics to Counseling: Are We Ready?

Those of us who are professional counselors are perhaps most likely to recognize psychedelic drugs by their recreational or street names — acid, magic mushrooms, ecstasy — and to consider them to be drugs of abuse that may be dangerous to our clients.

Article
Benjamin Hearn
2020
FindCenter AddIcon
FindCenter Post-Image

MDMA Lauded as ‘Breakthrough’ Therapy for PTSD Patients

The Food and Drug Administration (FDA) has approved the design of two Phase 3 clinical trials of MDMA for treating PTSD, according to the Multidisciplinary Association for Psychedelic Studies (MAPS), which is funding and leading the clinical trials.

Article
Maureen Meehan
2017
FindCenter AddIcon
FindCenter Post-Image

Johns Hopkins Scientists Give Psychedelics the Serious Treatment

Psychedelic drugs—once promising research subjects that were decades ago relegated to illicit experimentation in dorm rooms—have been steadily making their way back into the lab for a revamped 21st-century-style look.

Article
Tanya Lewis
2020
FindCenter AddIcon
FindCenter Post-Image

Can Psychedelic Experiences Cure Alcohol Addiction?

A new study hints at a novel and promising treatment for alcohol use disorder.

Article
Mark Travers
2019
FindCenter AddIcon
FindCenter Post-Image

LSD May Help Treat Alcoholism

The psychedelic drug LSD can help people with alcoholism quit or cut back their drinking, according to a new analysis of data originally collected in the 1960s. The study adds to a renaissance of research interest in mind-expanding medications for psychiatric disorders.

Article
Maia Szalavitz
2012
FindCenter AddIcon
FindCenter Post-Image

Crash Course in the Nature of Mind

Roland Griffiths' psilocybin experiments have produced striking evidence for therapeutic uses of hallucinogens.

Article
Julie Scharper
FindCenter AddIcon

EXPLORE TOPIC

Altered States of Consciousness